
3M gave Wall Street and Maplewood something to cheer about, hiking its full-year adjusted earnings outlook after a stronger-than-expected second quarter that pushed the stock higher on Tuesday. Executives credited operational improvement and firmer organic sales for the beat, even as the company continues to face a thicket of legal and regulatory issues. For Twin Cities investors and employees, the show of momentum from the hometown industrial heavyweight was a welcome change of pace.
The company reported adjusted earnings of $2.40 per share on about $6.5 billion in revenue for the June quarter, topping analyst estimates. Investing.com noted the performance amounted to roughly a $0.16 per-share beat. On the heels of those results, 3M lifted its 2026 adjusted EPS guidance to a range of $8.80 to $8.95, up from a prior range of $8.50 to $8.70, according to the Minneapolis / St. Paul Business Journal.
Operational momentum
Company leaders pointed to improved execution, firmer pricing and gains in key markets as the main drivers behind the upside. Seeking Alpha summarized management’s commentary, highlighting that safety-and-industrial operations and growth in China were called out in the company’s reports and filings as meaningful contributors.
Market reaction and local meaning
Investors wasted little time reacting. Shares climbed roughly 6% in premarket trading after the earnings release, according to Investing.com, as traders digested the beat and higher guidance. The move was closely watched in Maplewood and across the Twin Cities, where 3M has been a corporate fixture for generations; 3M identifies its longstanding headquarters in Maplewood.
Legal risks still loom
Analysts are quick to note that the brighter earnings outlook does not erase the company’s legal overhang. 3M’s regulatory filings with the Securities and Exchange Commission continue to spotlight liabilities related to PFAS litigation and other legal matters that could weigh on future results. The company’s Form 8-K and related investor materials list PFAS-related claims as a key risk to its forward-looking statements, with an SEC filing detailing those contingencies as an important caveat for investors sizing up the latest quarter’s good news.









